Pentobarbital capabilities within the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This motion potentiates GABA effects, causing CNS depression and inhibiting glutamate, even more bringing about an additive effect on CNS despair. Although the not enough an antidote has led to diminished initial-line utilization of your drug